SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Skinvisible, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-31.1’

On:  Monday, 11/14/22, at 12:58pm ET   ·   For:  9/30/22   ·   Accession #:  1663577-22-653   ·   File #:  0-25911

Previous ‘10-Q’:  ‘10-Q’ on 8/10/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/10/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/15/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/22  Skinvisible, Inc.                 10-Q        9/30/22   46:2.5M                                   Edgar Einsteins, Inc./FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    519K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     18K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
10: R1          Cover                                               HTML     63K 
11: R2          Condensed Consolidated Balance Sheets               HTML    107K 
12: R3          Condensed Consolidated Balance Sheets               HTML     28K 
                (Parenthetical)                                                  
13: R4          Condensed Consolidated Statements of Operations     HTML     91K 
                (Unuadited)                                                      
14: R5          Consolidated Statements of Stockholders' Deficit    HTML     50K 
                (Unaudited)                                                      
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     96K 
                (Unaudited)                                                      
16: R7          1. Description of Business and History              HTML     20K 
17: R8          2. Basis of Presentation and Going Concern          HTML     22K 
18: R9          3. Summary of Significant Policies                  HTML     35K 
19: R10         4. Intangible and Other Assets                      HTML     19K 
20: R11         5. Related Party Transactions                       HTML     30K 
21: R12         6. Notes Payable                                    HTML     43K 
22: R13         8. Stock Options and Warrants                       HTML     29K 
23: R14         9. Commitments and Contingencies                    HTML     23K 
24: R15         10. Stockholders? Deficit                           HTML     23K 
25: R16         11. Subsequent Events                               HTML     17K 
26: R17         2. Basis of Presentation and Going Concern          HTML     23K 
                (Policies)                                                       
27: R18         3. Summary of Significant Policies (Policies)       HTML     58K 
28: R19         5. Related Party Transactions (Tables)              HTML     26K 
29: R20         6. Notes Payable (Tables)                           HTML     35K 
30: R21         8. Stock Options and Warrants (Tables)              HTML     27K 
31: R22         1. Description of Business and History (Details     HTML     16K 
                Narrative)                                                       
32: R23         2. Basis of Presentation and Going Concern          HTML     27K 
                (Details Narrative)                                              
33: R24         3. Summary of Significant Policies (Details         HTML     25K 
                Narrative)                                                       
34: R25         4. Intangible and Other Assets (Details Narrative)  HTML     22K 
35: R26         5. RELATED PARTY TRANSACTIONS - Schedule of         HTML     58K 
                Convertible Notes Payable Related Party (Details)                
36: R27         5. Related Party Transactions (Details Narrative)   HTML     24K 
37: R28         7. CONVERTIBLE NOTES PAYABLE - Schedule of          HTML     81K 
                Convertible Notes Payable (Details)                              
38: R29         6. Notes Payable (Details Narrative)                HTML     26K 
39: R30         8. STOCK OPTIONS AND WARRANTS - Schedule of Option  HTML     45K 
                Summary (Details)                                                
40: R31         9. Commitments and Contingencies (Details           HTML     23K 
                Narrative)                                                       
41: R32         10. Stockholders? Deficit (Details Narrative)       HTML     23K 
44: XML         IDEA XML File -- Filing Summary                      XML     79K 
42: XML         XBRL Instance -- skvi10q_htm                         XML    460K 
43: EXCEL       IDEA Workbook of Financial Reports                  XLSX     65K 
 6: EX-101.CAL  XBRL Calculations -- skvi-20220930_cal               XML     98K 
 7: EX-101.DEF  XBRL Definitions -- skvi-20220930_def                XML    163K 
 8: EX-101.LAB  XBRL Labels -- skvi-20220930_lab                     XML    434K 
 9: EX-101.PRE  XBRL Presentations -- skvi-20220930_pre              XML    357K 
 5: EX-101.SCH  XBRL Schema -- skvi-20220930                         XSD     72K 
45: JSON        XBRL Instance as JSON Data -- MetaLinks              195±   278K 
46: ZIP         XBRL Zipped Folder -- 0001663577-22-000653-xbrl      Zip    134K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



CERTIFICATIONS

 

I, Terry Howlett, certify that;

 

1.   I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 of Skinvisible, Inc. (the “registrant”);

 

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2022

 

/s/ Terry Howlett

By: Terry Howlett

Title: Chief Executive Officer


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/14/22None on these Dates
For Period end:9/30/22
 List all Filings 
Top
Filing Submission 0001663577-22-000653   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 3:34:15.1am ET